DK0744938T3 - Flydende oftalmisk afgivelsessystem med vedholdende afgivelse - Google Patents

Flydende oftalmisk afgivelsessystem med vedholdende afgivelse

Info

Publication number
DK0744938T3
DK0744938T3 DK95906463T DK95906463T DK0744938T3 DK 0744938 T3 DK0744938 T3 DK 0744938T3 DK 95906463 T DK95906463 T DK 95906463T DK 95906463 T DK95906463 T DK 95906463T DK 0744938 T3 DK0744938 T3 DK 0744938T3
Authority
DK
Denmark
Prior art keywords
ophthalmic
polymer
mammal
eye
sustained release
Prior art date
Application number
DK95906463T
Other languages
English (en)
Inventor
Shau-Fong Yen
Kenneth W Reed
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of DK0744938T3 publication Critical patent/DK0744938T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
DK95906463T 1994-02-18 1995-02-09 Flydende oftalmisk afgivelsessystem med vedholdende afgivelse DK0744938T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/198,924 US5422116A (en) 1994-02-18 1994-02-18 Liquid ophthalmic sustained release delivery system
PCT/IB1995/000082 WO1995022315A1 (en) 1994-02-18 1995-02-09 Liquid ophthalmic sustained release delivery system

Publications (1)

Publication Number Publication Date
DK0744938T3 true DK0744938T3 (da) 2001-12-31

Family

ID=22735469

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95906463T DK0744938T3 (da) 1994-02-18 1995-02-09 Flydende oftalmisk afgivelsessystem med vedholdende afgivelse

Country Status (21)

Country Link
US (1) US5422116A (da)
EP (1) EP0744938B1 (da)
JP (1) JP3720359B2 (da)
CN (1) CN1138530C (da)
AT (1) ATE205079T1 (da)
AU (1) AU704353B2 (da)
CA (1) CA2181715C (da)
CY (1) CY2314B1 (da)
DE (1) DE69522550T2 (da)
DK (1) DK0744938T3 (da)
ES (1) ES2163495T3 (da)
FI (1) FI117851B (da)
GR (1) GR3036884T3 (da)
IL (1) IL112674A (da)
MX (1) MX9603435A (da)
NO (1) NO313861B1 (da)
NZ (1) NZ278668A (da)
PT (1) PT744938E (da)
TW (1) TW317501B (da)
WO (1) WO1995022315A1 (da)
ZA (1) ZA951323B (da)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5762903A (en) * 1995-03-10 1998-06-09 Korea Atomic Energy Research Institute Radioactive chitosan complex for radiation therapy
AU708540B2 (en) * 1995-06-06 1999-08-05 Bayer Intellectual Property Gmbh Non-irritation, nonsensitizing, non-ototoxic otic anti-bacterial compositions
US5843930A (en) * 1995-06-06 1998-12-01 Bayer Corporation Method of treating otitis with ciprofloxacin-hydrocortisone suspension
TW389694B (en) * 1995-08-17 2000-05-11 Novartis Ag Compositions including o-carboxyalkyl chitosan and methods of use in ophthalmics
WO1997007139A2 (en) * 1995-08-17 1997-02-27 Novartis Ag Stabilized chitin derivative compounds
US5641750A (en) * 1995-11-29 1997-06-24 Amgen Inc. Methods for treating photoreceptors using glial cell line-derived neurotrophic factor (GDNF) protein product
US5641749A (en) * 1995-11-29 1997-06-24 Amgen Inc. Method for treating retinal ganglion cell injury using glial cell line-derived neurothrophic factor (GDNF) protein product
US6071904A (en) * 1996-12-11 2000-06-06 Alcon Laboratories, Inc. Process for manufacturing ophthalmic suspensions
CA2212300A1 (en) 1997-08-04 1999-02-04 Abdellatif Chenite In vitro or in vivo gelfying chitosan and therapeutic uses thereof
US6174524B1 (en) 1999-03-26 2001-01-16 Alcon Laboratories, Inc. Gelling ophthalmic compositions containing xanthan gum
US6261547B1 (en) 1998-04-07 2001-07-17 Alcon Manufacturing, Ltd. Gelling ophthalmic compositions containing xanthan gum
PT1676579E (pt) * 1998-05-08 2009-03-24 Univ Miami Utilização de tetraciclinas sub-antimicrobianas para o tratamento de rosácea ocular
US7288532B1 (en) * 1998-08-21 2007-10-30 The University Of Maryland Biotechnology Institute Modified chitosan polymers and enzymatic methods for the production thereof
US20040152664A1 (en) * 1998-09-02 2004-08-05 Allergan, Inc. Prednisolone compositions
US6214381B1 (en) 1998-09-08 2001-04-10 Effcon, Inc. Methazolamide composition and method of use
DK1128809T3 (da) * 1998-11-20 2005-04-25 Medidom Lab Vandige oftalmiske formuleringer omfattende chitosan
ATE252887T1 (de) * 1999-09-24 2003-11-15 Alcon Inc Topische suspensionsformulierungen enthaltend ciprofloxacin und dexamethason
CN1384745A (zh) 1999-11-01 2002-12-11 爱尔康公司 含有一种氟喹诺酮抗生素和黄原酸胶的药物组合物
WO2001036000A1 (en) * 1999-11-15 2001-05-25 Bio Syntech Canada, Inc. Temperature-controlled and ph-dependant self-gelling biopolymeric aqueous solution
KR100371092B1 (ko) * 1999-12-09 2003-02-05 주식회사대성미생물연구소 동물용 복합항균제 조성물
US20030158302A1 (en) * 1999-12-09 2003-08-21 Cyric Chaput Mineral-polymer hybrid composition
ATE243049T1 (de) * 1999-12-09 2003-07-15 Biosyntech Canada Inc Mineral-polymer hybrid-zusammensetzung
US6348508B1 (en) * 2000-04-04 2002-02-19 Bausch & Lomb Incorporated Method for treating dry eye
US6716970B2 (en) 2000-04-21 2004-04-06 Adjuvant Pharmaceuticals, Llc Water soluble, randomly substituted partial N-partial O-acetylated chitosan, preserving compositions containing chitosan, and processes for making thereof
ES2195819T3 (es) * 2000-05-26 2003-12-16 Medidom Lab Formulaciones oftalmicas acuosas antibacterianas que contiene ofloxacino y chitosan.
JP5089006B2 (ja) * 2000-06-29 2012-12-05 ピラマル ヘルスケア (カナダ) リミテッド 軟骨および他の組織の修復および再生のための組成物および方法
EP1305033B1 (en) 2000-07-28 2004-10-20 Alcon, Inc Pharmaceutical compositions containing tobramycin and xanthan gum
WO2002040070A2 (en) * 2000-11-15 2002-05-23 Bio Syntech Canada Inc. Method for restoring a damaged or degenerated intervertebral disc
US6720003B2 (en) * 2001-02-16 2004-04-13 Andrx Corporation Serotonin reuptake inhibitor formulations
AR034372A1 (es) * 2001-06-08 2004-02-18 Novartis Ag Composiciones farmaceuticas
US20030124679A1 (en) * 2001-06-27 2003-07-03 Short Jay M. Glycosylated kinamycins and methods of making and using them
ATA13842001A (de) * 2001-08-31 2002-10-15 Mucobiomer Biotechnologische F Chitosan-thio-alkyl-amidin konjugate und deren kosmetische sowie pharmazeutische verwendung
AU2003249805A1 (en) * 2002-07-16 2004-02-02 Bio Syntech Canada Inc. Composition for cytocompatible, injectable, self-gelling chitosan solutions for encapsulating and delivering live cells or biologically active factors
US20070172821A1 (en) * 2002-08-23 2007-07-26 Li-Qun Wu Assembly of chitosan onto an electrode surface
AU2003275289A1 (en) * 2002-09-26 2004-04-19 University Of Maryland Baltimore County Polysaccharide-based polymers and methods of making the same
US7790010B2 (en) * 2002-12-20 2010-09-07 University Of Maryland, College Park Spatially selective deposition of polysaccharide layer onto patterned template
TW200416046A (en) * 2002-12-23 2004-09-01 Alcon Inc Contact lens care compositions containing chitin derivatives
GB0300531D0 (en) 2003-01-10 2003-02-12 West Pharm Serv Drug Res Ltd Pharmaceutical compositions
KR20050108345A (ko) * 2003-01-24 2005-11-16 컨트롤 딜리버리 시스템즈 인코포레이티드 탄산 탈수효소 저해제의 안구 전달을 위한 서방 장치와방법
US7883615B2 (en) * 2003-02-12 2011-02-08 University Of Maryland, College Park Controlled electrochemical deposition of polysaccharide films and hydrogels, and materials formed therefrom
MXPA05008913A (es) * 2003-02-21 2005-10-05 Sun Pharmaceutical Ind Ltd Formulacion oftalmica estable que contiene antibiotico y corticoesteroide.
US20040202687A1 (en) * 2003-04-14 2004-10-14 Babu M.K. Manoj Ciprofloxacin formulations and methods of making and using the same
US6933289B2 (en) 2003-07-01 2005-08-23 Allergan, Inc. Inhibition of irritating side effects associated with use of a topical ophthalmic medication
US7125967B2 (en) * 2003-10-08 2006-10-24 Adjuvant Pharmaceuticals, Llc Water-soluble chitosan having low endotoxin concentration and methods for making and using the same
US20050101582A1 (en) * 2003-11-12 2005-05-12 Allergan, Inc. Compositions and methods for treating a posterior segment of an eye
US7375404B2 (en) * 2003-12-05 2008-05-20 University Of Maryland Biotechnology Institute Fabrication and integration of polymeric bioMEMS
GB0403938D0 (en) * 2004-02-21 2004-03-24 West Pharm Serv Drug Res Ltd Chitosan containing solution
KR101080056B1 (ko) * 2004-12-01 2011-11-04 한국원자력연구원 체내 주사시 겔화 안정성이 개선된 방사성물질-키토산복합체용액 조성물 및 그 제조 방법
DE602005007319D1 (de) * 2005-02-17 2008-07-17 Jordanian Pharmaceutical Mfg Zubereitung zur kontinuierlichen Arzneimittelfreisetzung Chitosan enthaltend
US8088773B2 (en) 2005-05-12 2012-01-03 The Texas A&M University System Therapeutic compositions and methods
EP1945712A4 (en) * 2005-11-04 2013-05-01 Piramal Healthcare Canada Ltd BINDING OF AQUEOUS POLYELECTROLYTE SOLUTIONS BY THERMALLY INDUCED CHANGES IN THE IONIZATION CONDITION
NZ568694A (en) 2005-11-09 2011-09-30 Zalicus Inc Method, compositions, and kits for the treatment of medical conditions
US20070154523A1 (en) * 2005-12-30 2007-07-05 Rick Lewis Controlled pupil dilation for diagnostic and treatment of visual anomalies
US7785624B2 (en) * 2006-03-02 2010-08-31 Inspire Pharmaceuticals, Inc. Pharmaceutical latrunculin formulations
DK1938839T3 (da) * 2006-12-18 2009-11-30 Jorge Luis Benozzi Oftalmiske sammensætninger af parasympatiske stimulanter og anti-inflammatoriske midler til anvendelse i behandlingen af presbyopi
CA2676919C (en) * 2007-01-31 2013-01-29 Allergan, Inc. Novel biomaterials for ocular drug delivery and a method for making and using same
US20080213188A1 (en) * 2007-03-02 2008-09-04 Saint Simeon Lda Novel ophthalmic compositions containing human recombinant lysozyme and use thereof for treating eye conditions and as contact lens solutions
JP2010539245A (ja) 2007-09-14 2010-12-16 日東電工株式会社 薬物担体
CN101780105B (zh) * 2009-01-20 2011-09-28 沈阳兴齐制药有限公司 小牛血去蛋白提取物的滴眼液
US8299079B2 (en) 2009-05-22 2012-10-30 Kaufman Herbert E Preparations and methods for ameliorating or reducing presbyopia
US20100298335A1 (en) * 2009-05-22 2010-11-25 Kaufman Herbert E Preparations and Methods for Ameliorating or Reducing Presbyopia
WO2011018800A2 (en) 2009-08-13 2011-02-17 Fdc Limited A novel in-situ gel forming solution for ocular drug delivery
DE102010009475B4 (de) 2010-02-26 2011-11-24 F. Holzer Gmbh Verfahren zur Herstellung eines dosierbaren applikationsfertigen Präparates
US20120231072A1 (en) * 2011-03-11 2012-09-13 Chemisches Institut Schaefer Ag Thermo-responsive hydrogel compositions
DK2758047T3 (da) 2011-09-20 2019-04-01 Allergan Inc Sammensætninger og fremgangsmåder til behandling af presbyopi, mild hyperopi og irregulær astigmatisme
AU2013274582A1 (en) 2012-06-11 2015-01-22 Macuclear, Inc. Therapeutic formulation and methods of treatment
EP3057575B1 (en) * 2013-10-15 2021-09-08 Pharmathen S.A. Preservative free pharmaceutical compositions for ophthalmic administration
TWI609701B (zh) 2016-01-05 2018-01-01 國立交通大學 滴點式複合藥物凝膠及其製備方法
WO2018033792A2 (en) 2016-08-19 2018-02-22 Orasis Pharmaceuticals Ltd. Ophthalmic pharmaceutical compositions and uses relating thereto
CN106511268A (zh) * 2017-01-22 2017-03-22 吉林省始祖生物波医学研究院有限公司 治疗眼病的溶液及其应用、眼贴及其制作方法
US9980946B1 (en) 2017-01-25 2018-05-29 Effcon Laboratories, Inc. Extended release methazolamide formulation
MX2020008925A (es) * 2018-02-28 2020-10-01 Santen Pharmaceutical Co Ltd Composicion oftalmica que comprende dicuafosol y polimero cationico.
US20210038612A1 (en) * 2018-04-03 2021-02-11 Hyderabad Eye Research Foundation Mucoadhesive drug delivery system for ocular administration of fluoroquinolone antibiotics
LT3681500T (lt) 2018-04-24 2022-06-27 Allergan, Inc. Pilokarpino hidrochlorido naudojimas presbiopijos gydymui
US11344507B2 (en) 2019-01-08 2022-05-31 Alumend, Llc Topical compositions containing low molecular weight chitosan derivatives
IT201900006104A1 (it) * 2019-04-18 2020-10-18 S I I T S R L Servizio Int Imballaggi Termosaldanti Metodo di preparazione di un prodotto a base di chitosano
CN111892667B (zh) * 2019-04-30 2024-02-20 苏州大学 含氟化合物修饰的阳离子聚合物在制备医疗美容及保健品中的应用
WO2021039748A1 (ja) * 2019-08-27 2021-03-04 参天製薬株式会社 ジクアホソルまたはその塩、およびポリビニルピロリドンを含有する水性眼科用組成物
CN114073670B (zh) * 2020-08-11 2023-02-24 武汉科福新药有限责任公司 马来酸噻吗洛尔凝胶滴眼液及其制备方法
JP2024505517A (ja) * 2021-01-28 2024-02-06 グラウコス コーポレイション 製剤

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4136173A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Mixed xanthan gum and locust beam gum therapeutic compositions
US4659700A (en) * 1984-03-02 1987-04-21 Johnson & Johnson Products, Inc. Chitosan-glycerol-water gel
EP0244178A3 (en) * 1986-04-28 1989-02-08 Iolab, Inc Intraocular dosage compositions and method of use
IT1190347B (it) * 1986-06-16 1988-02-16 Franco Conti Processo per la preparazione dell'n-dimetilchitosano e suoi impieghi farmacologici
JPS6471822A (en) * 1987-09-12 1989-03-16 Rohto Pharma Ophthalmic sustained release preparation
IE63392B1 (en) * 1988-02-08 1995-04-19 Insite Vision Inc Ophthalmic suspensions
FR2653021A1 (fr) * 1989-10-17 1991-04-19 Merck Sharp & Dohme Composition ophtalmique aqueuse liquide a transition de phase liquide-gel.
JPH0418022A (ja) * 1990-05-10 1992-01-22 Fujikawa Kk ピロキシカムの安定水溶液ならびにその製造法
CA2064160C (en) * 1991-03-27 1998-08-11 Paul J. T. Missel Use of combinations of gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions
US5318780A (en) * 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels

Also Published As

Publication number Publication date
GR3036884T3 (en) 2002-01-31
CA2181715C (en) 2006-05-30
FI963217A0 (fi) 1996-08-16
NO963431D0 (no) 1996-08-16
ES2163495T3 (es) 2002-02-01
FI117851B (fi) 2007-03-30
WO1995022315A1 (en) 1995-08-24
AU1464995A (en) 1995-09-04
IL112674A (en) 1999-12-22
MX9603435A (es) 1997-03-29
TW317501B (da) 1997-10-11
FI963217A (fi) 1996-08-16
JPH09509166A (ja) 1997-09-16
NO313861B1 (no) 2002-12-16
NZ278668A (en) 1998-01-26
ZA951323B (en) 1995-08-18
JP3720359B2 (ja) 2005-11-24
EP0744938B1 (en) 2001-09-05
PT744938E (pt) 2001-12-28
CY2314B1 (en) 2003-11-14
IL112674A0 (en) 1995-05-26
NO963431L (no) 1996-10-09
CA2181715A1 (en) 1995-08-24
EP0744938A1 (en) 1996-12-04
AU704353B2 (en) 1999-04-22
ATE205079T1 (de) 2001-09-15
CN1140988A (zh) 1997-01-22
DE69522550D1 (de) 2001-10-11
US5422116A (en) 1995-06-06
CN1138530C (zh) 2004-02-18
DE69522550T2 (de) 2002-05-02

Similar Documents

Publication Publication Date Title
DK0744938T3 (da) Flydende oftalmisk afgivelsessystem med vedholdende afgivelse
US5358706A (en) Muco-adhesive polymers
DE69424275T2 (de) Alkalische ophthalmische suspensionen
EP0799615B1 (en) Liposome eye drops
US5209927A (en) Ophthalmic solution
DE69706410D1 (de) Mit tamarindensamenpolysacchariden verdickte opthalmische lösungen
CN101312711B (zh) 不含右泛醇、钙离子和磷酸盐的药物组合物以及钙螯合剂和眼科相容粘度调节剂的应用
ES2161874T3 (es) Composicion oftalmica con viscosidad reducida.
IL114193A0 (en) Ophthalmic pharmaceutical compositions
KR20000068632A (ko) 하드 콘택트 렌즈 보호용 컨디셔닝 용액
US5645827A (en) Muco-adhesive polymers
DE69432188D1 (de) Synthetisches Viskoseelastisches Material für physiologische Anwendungen wie für Ophtalmologische Anwendungen
JPH08510731A (ja) 治療使用のためのその場で生成するゲル
FI940081A0 (fi) Polyakryylihappopohjaisia silmätulehduksenvastaisia koostumuksia
WO1984004680A1 (en) Ophthalmic gel
WO2007007076A1 (en) Contact lens care solution